BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 7977843)

  • 41. A non-competitive type of angiotensin-receptor antagonism by losartan in renal artery preparations.
    Zhang J; Pfaffendorf M; Zhang JS; Van Zwieten PA
    Eur J Pharmacol; 1994 Feb; 252(3):337-40. PubMed ID: 8162955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices.
    Gyurko R; Kimura B; Kurian P; Crews FT; Phillips MI
    Biochem Biophys Res Commun; 1992 Jul; 186(1):285-92. PubMed ID: 1632771
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin II binding sites in aortic endothelium of domestic fowl.
    Stallone JN; Nishimura H; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):R777-82. PubMed ID: 2316722
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
    Christophe B; Libon R; Cazaubon C; Nisato D; Manning A; Chatelain P
    Eur J Pharmacol; 1995 Aug; 281(2):161-71. PubMed ID: 7589203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
    Yang Z; Arnet U; von Segesser L; Siebenmann R; Turina M; Lüscher TF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S17-22. PubMed ID: 7508047
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential regulation of angiotensin II and losartan binding sites in glomeruli and mesangial cells.
    Chansel D; Bizet T; Vandermeersch S; Pham P; Levy B; Ardaillou R
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F384-93. PubMed ID: 8160786
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Angiotensin II receptors in the fowl aorta.
    Takei Y; Stallone JN; Nishimura H; Campanile CP
    Gen Comp Endocrinol; 1988 Feb; 69(2):205-16. PubMed ID: 3366355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of angiotensin II and its selective antagonists on inferior olivary neurones.
    Ambühl P; Felix D; Imboden H; Khosla MC; Ferrario CM
    Regul Pept; 1992 Sep; 41(1):19-26. PubMed ID: 1333623
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [125I]EXP985: a highly potent and specific nonpeptide radioligand antagonist for the AT1 angiotensin receptor.
    Chiu AT; McCall DE; Roscoe WA
    Biochem Biophys Res Commun; 1992 Nov; 188(3):1030-9. PubMed ID: 1445340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and structure-activity relationships of a novel series of non-peptide angiotensin II receptor binding inhibitors specific for the AT2 subtype.
    Blankley CJ; Hodges JC; Klutchko SR; Himmelsbach RJ; Chucholowski A; Connolly CJ; Neergaard SJ; Van Nieuwenhze MS; Sebastian A; Quin J
    J Med Chem; 1991 Nov; 34(11):3248-60. PubMed ID: 1956044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria.
    Gironacci MM; Adler-Graschinsky E; Peña C; Enero MA
    Hypertension; 1994 Oct; 24(4):457-60. PubMed ID: 8088911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological characterization of angiotensin II binding sites in the canine pancreas.
    Chappell MC; Diz DI; Jacobsen DW
    Peptides; 1992; 13(2):313-8. PubMed ID: 1409010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
    Höhle S; Spitznagel H; Rascher W; Culman J; Unger T
    Eur J Pharmacol; 1995 Mar; 275(3):277-82. PubMed ID: 7768295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Angiotensin II-mediated pressor effect of rat joining peptide.
    Yoshida M; Hamakubo T; Inagami T
    Am J Physiol; 1994 Mar; 266(3 Pt 2):R802-8. PubMed ID: 8160874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. NaCl injections in brain induce natriuresis and blood pressure responses sensitive to ANG II AT1 receptors.
    Rohmeiss P; Beyer C; Nagy E; Tschöpe C; Höhle S; Strauch M; Unger T
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F282-8. PubMed ID: 7653602
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Losartan, a specific angiotensin II receptor antagonist, increases angiotensin I and angiotensin II release from isolated rat hind legs: evidence for locally regulated renin-angiotensin system in vascular tissue.
    Mizuno K; Tani M; Niimura S; Sanada H; Haga H; Hashimoto S; Watanabe H; Ohtsuki M; Fukuchi S
    Life Sci; 1992; 50(23):PL209-14. PubMed ID: 1598061
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cloning of a rabbit kidney cortex AT1 angiotensin II receptor that is present in proximal tubule epithelium.
    Burns KD; Inagami T; Harris RC
    Am J Physiol; 1993 Apr; 264(4 Pt 2):F645-54. PubMed ID: 7916579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat.
    Kirby RF; Thunhorst RL; Johnson AK
    Brain Res; 1992 Apr; 576(2):348-50. PubMed ID: 1515929
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin II AT1 receptor mediated contraction of the perfused rat cerebral artery.
    Näveri L; Strömberg C; Saavedra JM
    Neuroreport; 1994 Nov; 5(17):2278-80. PubMed ID: 7881045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.